Literature DB >> 10499250

[Heparin and insulin in the treatment of acute hypertriglyceridemia-induced pancreatitis].

C Henzen1, M Röck, C Schnieper, K Heer.   

Abstract

Hypertriglyceridaemia is thought to be the aetiology in 3% of patients with acute pancreatitis, often associated with poorly controlled diabetes mellitus or chronic alcohol abuse. However, in patients with non-biliary pancreatitis, chylomicronaemia is an underrated cause of acute pancreatitis. The activity of lipoprotein lipase (LPL) is crucial in removing triglycerides from the plasma; LPL gene mutations combined with secondary alterations in plasma lipoproteins, such as occur in pregnancy, diabetes mellitus, and alcohol abuse can cause severe hypertriglyceridaemia and pancreatitis. Heparin and insulin stimulate LPL activity. During a 12 months' period we consecutively screened all patients with the diagnosis of acute non-biliary pancreatitis for hypertriglyceridaemia, to evaluate the prevalence of hypertriglyceridaemia-induced pancreatitis and to assess the outcome under standardised treatment with intravenous heparin and insulin. Hypertriglyceridaemia-induced pancreatitis was diagnosed in 5 out of 46 patients (11%) with acute pancreatitis. In 2 patients hypertriglyceridaemia was associated with diabetes mellitus, in one patient with pregnancy and in another with chronic alcohol abuse. Four patients had to be referred to the intensive care unit. Plasma concentrations of triglycerides were (median +/- range) 43 mmol/l (14.7 to 80.4); pancreas amylase was 574 U/l (155 to 1606), and lipase was 1003 U/l (330 to 3010). All patients had oedematous pancreatitis demonstrated by CT scan. Treatment with i.v. heparin and i.v. insulin decreased trigylceride levels to less than 10 mmol/l within 2.8 days (1 to 6), the amylase and lipase levels returned to normal after 3 and 4 days respectively, and the abdominal pain was resolved. Hypertriglyceridaemia is a common and under-diagnosed etiology of acute non-biliary pancreatitis. Intravenous heparin and insulin is safe and effective in the treatment of hypertriglyceridaemia-induced pancreatitis. Low fat diet, supplements of (n-3) fatty acids ("fish oil") and fibrates are recommended for long-term maintenance therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10499250

Source DB:  PubMed          Journal:  Schweiz Med Wochenschr        ISSN: 0036-7672


  15 in total

1.  Severe hypertriglyceridemia-induced pancreatitis during pregnancy.

Authors:  Alptekin Gürsoy; Mustafa Kulaksizoglu; Mustafa Sahin; Derun Taner Ertugrul; Feyza Ozer; Neslihan Bascil Tutuncu; Nilgun Guvener Demirag
Journal:  J Natl Med Assoc       Date:  2006-04       Impact factor: 1.798

2.  Treating hypertriglyceridemia.

Authors:  Georg Röggla; Michael Fasan; Stylianos Kapiotis
Journal:  CMAJ       Date:  2007-09-11       Impact factor: 8.262

Review 3.  Hypertriglyceridemia-induced pancreatitis: updated review of current treatment and preventive strategies.

Authors:  Prashanth Rawla; Tagore Sunkara; Krishna Chaitanya Thandra; Vinaya Gaduputi
Journal:  Clin J Gastroenterol       Date:  2018-06-19

Review 4.  Hypertriglyceridemia-induced pancreatitis: A case-based review.

Authors:  S-Ian Gan; Alun-L Edwards; Christopher-J Symonds; Paul-L Beck
Journal:  World J Gastroenterol       Date:  2006-11-28       Impact factor: 5.742

5.  Heparin and insulin in the treatment of hypertriglyceridemia-induced severe acute pancreatitis.

Authors:  Hakan Alagözlü; Mehmet Cindoruk; Tarkan Karakan; Selahattin Unal
Journal:  Dig Dis Sci       Date:  2006-05-03       Impact factor: 3.199

6.  Tamoxifen-induced severe hypertriglyceridaemia and acute pancreatitis.

Authors:  Hakan Alagozlu; Mehmet Cindoruk; Selahattin Unal
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

7.  Acute pancreatitis owing to very high triglyceride levels treated with insulin and heparin infusion.

Authors:  Madan Raj Aryal; Naba Raj Mainali; Shobhit Gupta; Manoj Singla
Journal:  BMJ Case Rep       Date:  2013-04-22

8.  Formalized therapeutic guideline for hyperlipidemic severe acute pancreatitis.

Authors:  En-Qiang Mao; Yao-Qing Tang; Sheng-Dao Zhang
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

9.  Transient massive hyperlipidaemia in a type 2 diabetic subject.

Authors:  G B Vigna; A Passaro; K Bonomo; G Anfossi; R Fellin; M Trovati
Journal:  Intern Emerg Med       Date:  2007-03-31       Impact factor: 3.397

10.  EFFICACY OF INSULIN, HEPARIN AND FENOFIBRATE COMBINATION TREATMENT IN SEVERE HYPERTRIGLYCERIDEMIA: DOUBLE CENTER EXPERIENCE.

Authors:  S Ozcelik; S Baş; M Ozcelik; M Sarıaydın; M Celik; H Gözü
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Oct-Dec       Impact factor: 0.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.